An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Veracyte Announces that New Afirma GRID Data Suggest Prognostic Ability of Molecular Testing for Thyroid Tumors Veracyte, Inc., announced new research findings suggesting the potential of novel molecular signatures to identify patients with thyroid nodules or cancer who have aggressive disease. […]
TOPICS IN THIS ARTICLE:
